FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200489430> ?p ?o ?g. }

• W4200489430 endingPage "1221" @default.
• W4200489430 startingPage "1201" @default.
• W4200489430 abstract "TOB1 is an anti-proliferative protein of Tob/BTG family and typically involved in the tumorigenesis and T cell activation. Although TOB1 is associated with T helper 17 cell-related autoimmunity, its role in modulating T cell-mediated immune responses in IBD remains poorly understood. Here, we explored its expression and the underlying mechanisms involved in the pathogenesis of inflammatory bowel disease (IBD).TOB1 and ID2 expression in IBD patients was examined by quantitative real time polymerase chain reaction and immunohistochemistry. IBD CD4+ T cells were transfected with lentivirus expressing TOB1, ID2, TOB1 short hairpin RNA and ID2 short hairpin RNA, respectively, and Tob1-/-CD4+ T cells were transfected with lentivirus expressing Id2. Experimental colitis was established in Tob1-/- mice by trinitrobenzene sulfonic acid enema and in Rag1-/- mice reconstituted with Tob1-/-CD45RBhighCD4+ T cells to further explore the role of Tob1 in intestinal mucosal inflammation. Splenic CD4+ T cells of Tob1-/- mice were sorted to determine transcriptome differences by RNA sequencing.TOB1 expression was decreased in inflamed mucosa and peripheral blood CD4+ T cells of IBD patients compared with healthy subjects. Overexpression of TOB1 downregulated IBD CD4+ T cells to differentiate into Th1/Th17 cells compared with control subjects. Severe colitis was observed in Tob1-/- mice through trinitrobenzene sulfonic acid enema or in Rag1-/- mice reconstituted with Tob1-/-CD45RBhighCD4+ T cells, compared with control animals. RNA sequencing analysis revealed ID2 as functional target of TOB1 to inhibit IBD CD4+ T cell differentiation into Th1/Th17 cells. Mechanistically, TOB1 was associated with Smad4/5 to induce ID2 expression and restrain Th1/Th17 cell differentiation.TOB1 restrains intestinal mucosal inflammation through suppressing Th1/Th17 cell-mediated immune responses via the Smad4/5-ID2 pathway. It may serve as a novel therapeutic target for treatment of human IBD." @default.
• W4200489430 created "2021-12-31" @default.
• W4200489430 creator A5005712222 @default.
• W4200489430 creator A5006930837 @default.
• W4200489430 creator A5009342500 @default.
• W4200489430 creator A5012288680 @default.
• W4200489430 creator A5018208175 @default.
• W4200489430 creator A5048710882 @default.
• W4200489430 creator A5065402321 @default.
• W4200489430 creator A5067765295 @default.
• W4200489430 creator A5073445503 @default.
• W4200489430 creator A5089120195 @default.
• W4200489430 date "2022-01-01" @default.
• W4200489430 modified "2023-10-11" @default.
• W4200489430 title "TOB1 Blocks Intestinal Mucosal Inflammation Through Inducing ID2-Mediated Suppression of Th1/Th17 Cell Immune Responses in IBD" @default.
• W4200489430 cites W1496930507 @default.
• W4200489430 cites W1514782836 @default.
• W4200489430 cites W1962764685 @default.
• W4200489430 cites W1967949491 @default.
• W4200489430 cites W1973307489 @default.
• W4200489430 cites W1980337975 @default.
• W4200489430 cites W1986546541 @default.
• W4200489430 cites W1997410198 @default.
• W4200489430 cites W1998605457 @default.
• W4200489430 cites W2025065287 @default.
• W4200489430 cites W2028896166 @default.
• W4200489430 cites W2048645473 @default.
• W4200489430 cites W2049690785 @default.
• W4200489430 cites W2050914686 @default.
• W4200489430 cites W2060933776 @default.
• W4200489430 cites W2075808173 @default.
• W4200489430 cites W2089457640 @default.
• W4200489430 cites W2097947458 @default.
• W4200489430 cites W2103747137 @default.
• W4200489430 cites W2111531099 @default.
• W4200489430 cites W2125164793 @default.
• W4200489430 cites W2133361872 @default.
• W4200489430 cites W2149093044 @default.
• W4200489430 cites W2149292237 @default.
• W4200489430 cites W2152720366 @default.
• W4200489430 cites W2176271034 @default.
• W4200489430 cites W2198600874 @default.
• W4200489430 cites W2406790975 @default.
• W4200489430 cites W2588714305 @default.
• W4200489430 cites W2620756707 @default.
• W4200489430 cites W2760522003 @default.
• W4200489430 cites W2766922625 @default.
• W4200489430 cites W2779904369 @default.
• W4200489430 cites W2935762014 @default.
• W4200489430 cites W2998028087 @default.
• W4200489430 cites W3006764495 @default.
• W4200489430 cites W3110516368 @default.
• W4200489430 cites W3114337463 @default.
• W4200489430 cites W3132374703 @default.
• W4200489430 cites W3143657138 @default.
• W4200489430 cites W3155681904 @default.
• W4200489430 cites W3197082108 @default.
• W4200489430 doi "https://doi.org/10.1016/j.jcmgh.2021.12.007" @default.
• W4200489430 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34920145" @default.
• W4200489430 hasPublicationYear "2022" @default.
• W4200489430 type Work @default.
• W4200489430 citedByCount "4" @default.
• W4200489430 countsByYear W42004894302022 @default.
• W4200489430 countsByYear W42004894302023 @default.
• W4200489430 crossrefType "journal-article" @default.
• W4200489430 hasAuthorship W4200489430A5005712222 @default.
• W4200489430 hasAuthorship W4200489430A5006930837 @default.
• W4200489430 hasAuthorship W4200489430A5009342500 @default.
• W4200489430 hasAuthorship W4200489430A5012288680 @default.
• W4200489430 hasAuthorship W4200489430A5018208175 @default.
• W4200489430 hasAuthorship W4200489430A5048710882 @default.
• W4200489430 hasAuthorship W4200489430A5065402321 @default.
• W4200489430 hasAuthorship W4200489430A5067765295 @default.
• W4200489430 hasAuthorship W4200489430A5073445503 @default.
• W4200489430 hasAuthorship W4200489430A5089120195 @default.
• W4200489430 hasBestOaLocation W42004894301 @default.
• W4200489430 hasConcept C153911025 @default.
• W4200489430 hasConcept C203014093 @default.
• W4200489430 hasConcept C2775862500 @default.
• W4200489430 hasConcept C2776090121 @default.
• W4200489430 hasConcept C2776914184 @default.
• W4200489430 hasConcept C502942594 @default.
• W4200489430 hasConcept C86803240 @default.
• W4200489430 hasConcept C8891405 @default.
• W4200489430 hasConceptScore W4200489430C153911025 @default.
• W4200489430 hasConceptScore W4200489430C203014093 @default.
• W4200489430 hasConceptScore W4200489430C2775862500 @default.
• W4200489430 hasConceptScore W4200489430C2776090121 @default.
• W4200489430 hasConceptScore W4200489430C2776914184 @default.
• W4200489430 hasConceptScore W4200489430C502942594 @default.
• W4200489430 hasConceptScore W4200489430C86803240 @default.
• W4200489430 hasConceptScore W4200489430C8891405 @default.
• W4200489430 hasFunder F4320321001 @default.
• W4200489430 hasFunder F4320335777 @default.
• W4200489430 hasIssue "4" @default.
• W4200489430 hasLocation W42004894301 @default.
• W4200489430 hasLocation W42004894302 @default.
• W4200489430 hasLocation W42004894303 @default.

• next